Read + Share
Amedeo Smart
Independent Medical Education
Boccara F, Caramelli B, Calmy A, Kumar P, et al. Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period. AIDS 2022 Jan 12. pii: 00002030-900000000-96231.PMID: 35025817
Email
LinkedIn
Facebook
Twitter
Privacy Policy